Alexion Pharmaceutical announced plans to expand its operations in Ireland. Alexion is a global biopharmaceutical company focused on serving patients with severe and life-threatening rare diseases.
The organisation is set to create 200 jobs upon completion of its €450 million facility in College Park in Blanchardstown, West Dublin.
In a statement released today, Alexion said the expansion project will take place over the next four years and will double its workforce to almost 500. On top of 200 full-time positions, 800 short-term construction jobs will also be created. Since first entering Ireland in 2013, Alexion has invested €130 million in Athlone facility and a Global Supply Chain facility at College Park.
See the full article in The Journal. For a full list of our available jobs, please visit www.clsrecruitment.ie